Posts for EUPRAXIA PHARMACEUTICALS INC. ($EPRX)

Eupraxia Pharmaceuticals Inc. submits its February 2025 Form 6-K, ensuring SEC compliance and announcing significant updates. Key insights and press release included.

Eupraxia Pharmaceuticals Inc. filed a Form 6-K with the SEC detailing its February 2025 activities, including a press release and annual report filing status.